Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexketoprofen/Tramadol FDC for Pain After Hip Arthroplasty
NCT01902134Phase 3Completed
- Sponsor
- Menarini Group
- Start
- Apr 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, double-blind trial of dexketoprofen + tramadol in acute pain (6 arms), sponsored by Menarini Group. Primary endpoint: Sum of Pain Intensity Differences Over 8 Hours. Started Apr 2013; status: completed.
02
Drugs
dexketoprofen + tramadol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT01902134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01902134.